Literature DB >> 11435567

Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

T Heise1, L G Guidotti, F V Chisari.   

Abstract

Hepatitis B virus (HBV) RNA is downregulated by inflammatory cytokines induced in the liver by adoptively transferred HBV-specific cytotoxic T lymphocytes (CTLs) and during murine cytomegalovirus (MCMV) infections of the livers of HBV transgenic mice. The disappearance of HBV RNA is tightly associated with the cytokine-induced proteolytic cleavage of a previously defined HBV RNA-binding protein known as La autoantigen. La binds to a predicted stem-loop structure at the 5' end of the posttranscriptional regulatory element of HBV RNA between nucleotides 1243 and 1333. In the present study, we searched for nuclear RNase activities that might be involved in HBV RNA decay. Nuclear extracts derived from control livers and CTL-injected and MCMV-infected livers were analyzed for the ability to cleave HBV RNA. Endonucleolytic activity that cleaved HBV RNA at positions 1269 to 1270 and 1271 to 1272, immediately 5' of the stem-loop bound by the La protein (positions 1272 to 1293), was detected. Furthermore, we provide evidence that the cytokine-dependent downregulation of HBV RNA following MCMV infection is temporally associated with the upregulation of the endonucleolytic activity herein described. Collectively, these results suggest a model in which the steady-state HBV RNA content is controlled by the stabilizing influence of La and the destabilizing influence of nuclear RNase activities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435567      PMCID: PMC114415          DOI: 10.1128/JVI.75.15.6874-6883.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Transport between the cell nucleus and the cytoplasm.

Authors:  D Görlich; U Kutay
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

2.  Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.

Authors:  K S Cunningham; R E Dodson; M A Nagel; D J Shapiro; D R Schoenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

Review 3.  Hormonal regulation of mRNA stability and RNA-protein interactions in the pituitary.

Authors:  J M Staton; A M Thomson; P J Leedman
Journal:  J Mol Endocrinol       Date:  2000-08       Impact factor: 5.098

Review 4.  Cytokine-mediated control of viral infections.

Authors:  L G Guidotti; F V Chisari
Journal:  Virology       Date:  2000-08-01       Impact factor: 3.616

Review 5.  The ends of the affair: capping and polyadenylation.

Authors:  A J Shatkin; J L Manley
Journal:  Nat Struct Biol       Date:  2000-10

6.  The poly(A)-binding protein and an mRNA stability protein jointly regulate an endoribonuclease activity.

Authors:  Z Wang; M Kiledjian
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.

Authors:  F V Chisari; C A Pinkert; D R Milich; P Filippi; A McLachlan; R D Palmiter; R L Brinster
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

10.  ard-1: a human gene that reverses the effects of temperature-sensitive and deletion mutations in the Escherichia coli rne gene and encodes an activity producing RNase E-like cleavages.

Authors:  M Wang; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

View more
  21 in total

Review 1.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 2.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

3.  Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.

Authors:  Jinjong Myoung; Don Ganem
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

4.  Role of the RNA-binding protein La in cancer pathobiology.

Authors:  Gunhild Sommer; Tilman Heise
Journal:  RNA Biol       Date:  2020-07-20       Impact factor: 4.652

Review 5.  Pathogenesis of hepatitis B virus infection.

Authors:  F V Chisari; M Isogawa; S F Wieland
Journal:  Pathol Biol (Paris)       Date:  2010-02-08

6.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Authors:  Xiuji Cui; Daniel N Clark; Kuancheng Liu; Xiao-Dong Xu; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

7.  Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.

Authors:  Dieter Glebe; Heike Lorenz; Wolfram H Gerlich; Scott D Butler; Ilia A Tochkov; Bud C Tennant; Paul Cote; Stephan Menne
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

8.  Inhibition of human La protein by RNA interference downregulates hepatitis B virus mRNA in 2.2.15 cells.

Authors:  Qin Ni; Zhi Chen; Hang-Ping Yao; Zheng-Gang Yang; Ke-Zhou Liu; Ling-Ling Wu
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

9.  Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA.

Authors:  Tavish Barnes; Wan-Cheol Kim; Anil K Mantha; Sang-Eun Kim; Tadahide Izumi; Sankar Mitra; Chow H Lee
Journal:  Nucleic Acids Res       Date:  2009-04-28       Impact factor: 16.971

10.  Increase of Plasma IL-12/p40 Ratio Induced by the Combined Therapy of DNA Vaccine and Lamivudine Correlates with Sustained Viremia Control in CHB Carriers.

Authors:  Se Jin Im; Se-Hwan Yang; Seung Kew Yoon; Young Chul Sung
Journal:  Immune Netw       Date:  2009-02-28       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.